Black Diamond Therapeutics, Inc. (BDTX)
2.665
-0.04
(-1.66%)
USD |
NASDAQ |
Dec 10, 16:00
2.69
+0.02
(+0.94%)
After-Hours: 20:00
Black Diamond Therapeutics EPS Diluted (Quarterly): -0.1493 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.121 |
| Puma Biotechnology, Inc. | 0.1736 |
| Cidara Therapeutics, Inc. | -3.096 |
| Oric Pharmaceuticals, Inc. | -0.3293 |
| Acumen Pharmaceuticals, Inc. | -0.4367 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.498M |
| Total Expenses (Quarterly) | 8.498M |
| Enterprise Value | 38.57M |
| Earnings Yield | 13.61% |
| Operating Earnings Yield | 7.81% |
| Normalized Earnings Yield | 13.61 |